[两例晚期乳腺癌经化疗内分泌治疗及放疗后获有效治疗]

[Two cases of advanced breast cancer effectively treated with chemoendocrine therapy and radiotherapy].

作者信息

Kimura M, Hagiwara S, Hirose K, Shimokawa Y, Iwai K, Uemura K

机构信息

Dept. of Surgery, Health Insurance Hitoyoshi General Hospital.

出版信息

Gan To Kagaku Ryoho. 1994 Oct;21(14):2505-8.

Abstract

We reported 2 cases of breast cancer with lymph node metastasis treated with CAF (cyclophosphamide, adriamycin, 5-fluorouracil) and medroxyprogesterone acetate (MPA). Case 1 was stage IV [T4b, N3 M1 (lung)] and case 2 was stage IIIa (T1, N2, M0). The two cases responded well to CAF and MPA therapy in local and systemic lesions, and then underwent radiotherapy and lymph node resection without mastectomy. After these treatments, both cases were thought to be disease-free. Major side effects were allopecia, obesity, and leukopenia. These results suggest that combination chemoendotherapy, radiotherapy, and surgery can be utilized for most patients with moderately advanced breast cancer.

摘要

我们报告了2例伴有淋巴结转移的乳腺癌患者，她们接受了CAF（环磷酰胺、阿霉素、5-氟尿嘧啶）和醋酸甲羟孕酮（MPA）治疗。病例1为IV期[T4b，N3 M1（肺）]，病例2为IIIa期（T1，N2，M0）。这两例患者的局部和全身病灶对CAF和MPA治疗反应良好，随后未行乳房切除术，而是接受了放疗和淋巴结切除术。经过这些治疗后，两例患者均被认为无疾病。主要副作用为脱发、肥胖和白细胞减少。这些结果表明，联合化疗、放疗和手术可用于大多数中晚期乳腺癌患者。

相似文献

1

[Two cases of advanced breast cancer effectively treated with chemoendocrine therapy and radiotherapy].[两例晚期乳腺癌经化疗内分泌治疗及放疗后获有效治疗]

Gan To Kagaku Ryoho. 1994 Oct;21(14):2505-8.

2

[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].一项随机对照研究，在辅助治疗背景下，比较尿嘧啶替加氟（UFT）+他莫昔芬（UFT + TAM疗法）与环磷酰胺+阿霉素+ 5-氟尿嘧啶（CAF疗法）用于治疗有四个或更多受累淋巴结的I、II或IIIa期乳腺癌女性患者的疗效。

Gan To Kagaku Ryoho. 2006 Oct;33(10):1423-9.

3

[A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].[一例晚期乳腺癌对化疗内分泌治疗（CTF + MPA）反应显著的病例报告]

Gan To Kagaku Ryoho. 1998 Apr;25(5):739-42.

4

[A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].1例乳腺癌伴多器官转移对CAF（环磷酰胺、阿霉素和5-氟尿嘧啶）、去氧氟尿苷和醋酸甲羟孕酮联合治疗反应显著

Gan To Kagaku Ryoho. 2000 Dec;27(14):2235-8.

5

[Study on CAF + medroxyprogesterone acetate (MPA) therapy for advanced or recurrent breast cancer--comparison between MPA 600 mg and 1,200 mg. Kyushu CAFT Therapy Study Group (Third Study)].

Gan To Kagaku Ryoho. 1999 Nov;26(13):2029-36.

6

[A case of complete remission of breast cancer with bilateral multiple lung metastases by combination therapy of MPA, THP, CPM and 5-FU].[一例通过甲孕酮、吡柔比星、环磷酰胺和5-氟尿嘧啶联合治疗实现双侧多发性肺转移乳腺癌完全缓解的病例]

Gan To Kagaku Ryoho. 1993 Mar;20(4):521-4.

7

Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).比较新辅助化疗与辅助化疗用于可手术局部晚期乳腺癌（T4b N0-2 M0）的随机试验。

J Surg Oncol. 2003 Dec;84(4):192-7. doi: 10.1002/jso.10323.

8

[Effects of neoadjuvant intra-arterial infusion chemotherapy in patients with stage III breast carcinoma].[新辅助动脉内灌注化疗对III期乳腺癌患者的影响]

Gan To Kagaku Ryoho. 1997 Sep;24(12):1799-802.

9

Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.局部晚期IIIB期乳腺癌的新辅助化疗

Oncol Rep. 2004 Jun;11(6):1265-72.

10

[Clinical evaluation of adriamycin in advanced and recurrent breast cancer (No. 4)--Joint study by 30 institutes on the duration of remission using various maintenance therapies in patients treated with CAF. Clinical Study Group of Adriamycin for Breast Cancer in Japan].阿霉素治疗晚期及复发性乳腺癌的临床评估（第4号）——日本30家机构关于CAF方案治疗患者采用不同维持疗法的缓解期联合研究。日本乳腺癌阿霉素临床研究组

Gan To Kagaku Ryoho. 1988 Jun;15(6):1863-71.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。